Sechrist Industries Approved Chamber Cleaners document (P/N 100397 Rev 2): is the most up to date listing of cleaners which have been tested and approved to be utilized on Sechrist monoplace hyperbaric chambers. Specifically, these products have been tested and deemed safe for use on the acrylic cylinder. These are the only cleaning agents that should be used on the Sechrist acrylic cylinders. Since information is becoming available daily, we suggest that your facility keep in contact with the manufacturer of the cleaning agent utilized to determine any new information available about the effectiveness against novel coronavirus. We also suggest that each healthcare facility should utilize the CDC website to review information for Healthcare Professionals and Resources for Healthcare Facilities. Thank you for your cooperation and understanding.
Supply Chain Notification : Sechrist Industries has reviewed if there is any potential impact to our supply chain as well as the production of our respiratory and hyperbaric products. The Sechrist Supply Chain team has been in contact with all of our suppliers and at this time there is no issue with the continuity of items from our suppliers.
Our team is continuing to monitor the situation and we are committed to continuing our supply to you, our valued customer.
Right now, the team at Sechrist Industries is doing our utmost to support the brave clinicians around the world in their fight against the global pandemic, coronavirus (COVID-19). With all that is happening respective to global COVID-19 pandemic, we want to promise you that we are here to support you in any way we can.
We are dedicated to design and produce safe, reliable, durable, cost-effective and innovative health care solutions. We are committed to the safety of the patients and their caregivers. For this reason we are working diligently to make sure that both our hyperbaric oxygen therapy division and respiratory division are continuing to maintain our production levels to meet all the needs of the clinicians utilizing our products.
We believe that saving lives is the greatest job in the world. We are proud to be a part of your efforts in this fight. As your partner in healing, we want you to know that we are doing everything possible to provide product, support and assistance. As the information regarding COVID-19 is continually changing, please continue to check back here for updated information.
Sechrist Industries Approved Chamber Cleaners document (P/N 100397) is the most up to date listing of cleaners which have been tested and approved to be utilized on Sechrist monoplace hyperbaric chambers. Specifically, these products have been tested and deemed safe for use on the acrylic cylinder. These are the only cleaning agents that should be used on the Sechrist acrylic cylinders.
Since information is becoming available daily, we suggest that your facility keep in contact with the manufacturer of the cleaning agent utilized to determine any new information available about the effectiveness against novel coronavirus. We also suggest that each healthcare facility should refer to the EPA Coronavirus (COVID-19) website and the Centers for Disease Control and Prevention website to review information for Healthcare Professionals and Resources for Healthcare Facilities. Thank you for your cooperation and understanding.
| DISINFECTANT | MANUFACTURER | EPA REGISTRATION NUMBER | RECOMMENDED DILUTION WITH WATER | STRENGTH APPROVED FOR USE | APPROVED AT RECOMMENDED DILUTION |
|---|---|---|---|---|---|
| Asepti-HB | Ecolab Professional Products Ecolab Inc. | 61178-2-1677 | Ready to use | Ready to use | N/A |
| Virasept | Ecolab Professional Products Ecolab Inc. | 1677-226 | Ready to use | Ready to use | N/A |
| Oxycide Daily Disinfectant | Ecolab Professional Products Ecolab Inc. | 1677-237 | 1:128-1:64 | 1:128-1:64 | YES |
| Neutral Disinfectant Cleaner | Ecolab Professional Products Ecolab Inc. | 47371-129 | 1:128-1:64 | 1:128-1:64 | YES |
| Stat III TB | Ecolab Professional Products Ecolab Inc. | 39967-89-2677 | 1:128 | 1:128 | YES |
| LpH-se | Calgon, Vestal Division STERIS Corp. | N/A | 1:256 | 1:256 | YES |
| Sani-Cloth Bleach Wipe | PDI/Nicepak | 9480-8 | Equivalent to 1:10 dilution | Ready to use | N/A |
| Clorox Healthcare Bleach Germicidal Cleaner | Clorox Professional Products | 67619-12 | Ready to Use | Ready to use | N/A |
| Quaternary Disinfectant Cleaner | ECOLAB Professional Products | 6836-78 | 1:256-1:64 | Ready to use | YES |
| Coverage® Spray HB PLus | Steris Corporation | 6836-152 | Ready to Use | Ready to use | N/A |
| Sani-Cloth® HB Wipe | PDI/Nicepak | 61178-4-9480 | Ready to Use | Ready to use | N/A |
| Virex II 256 | Diversey | 70627-24 | 1:128 | 1:128 | YES |
| Virex Plus | Diversey | 6836-349 | 1:128 | 1:128 | YES |
As we all steer through this unparalleled experience presented by the COVID-19 pandemic, we at Sechrist are committed to keeping you informed. On this page, we are providing some useful resources for you and your team. Special thanks to the Undersea & Hyperbaric Medical Society (UHMS), American College of Hyperbaric Medicine (ACHM) and the Association for the Advancement of Wound Care (AAWC) for continuing to update our industry on current information regarding COVID-19.
UHMS
• Synopsis: UHMS Hyperbaric Oxygen Therapy Committee Meeting on COVID-19 and HBO2
• UHMS Position Statement: Hyperbaric Oxygen (HBO2) for COVID-19 Patients
• Disinfecting hyperbaric chambers concerning COVID-19
ACHM
• Webinar – COVID-19 and HBO: What We Know and What We Don’t, May 7 at 12:30pm CST Click here to view recording of webinar
The unique aspects of COVID-19 have challenged the world’s physicians, clinicians and researchers to find a variety of effective treatment modalities. With ventilators in short supply and the pursuit of a vaccination still underway, the use of other treatments is being developed rapidly including ECMO (Extracorporeal Membrane Oxygenation), helmet-based ventilation and medications not yet approved for COVID-19. As a part of the search for additional effective treatments, some in the hyperbaric community have initiated clinical trials to evaluate the use of hyperbaric oxygen therapy for COVID-19 patients. Below are links for clinical trials currently registered with the National Institute of Health.
Hyperbaric Oxygen Therapy (HBOT) as a Treatment for COVID-19 Infection
• Oschner Medical Center, New Orleans LA; Sponsored by Oschner Health System
Hyperbaric Oxygen for COVID-19 Patients
• NYU Winthrop Hospital, Mineola, NY; Sponsored by NYU Langone Health
Safety and Efficacy of Hyperbaric Oxygen and ARDS in Patients with COVID-19
• Sponsored by Karolinska University Hospital in collaboration with Karolinska Institutet, University of California, San Diego and Blekinge County Council Hospital
Management by Hyperbaric Oxygen Therapy of Patients with Hypoxaemic Pneumonia with SARS-CoV-2 (COVID-19)
• Sainte Anne Militry Teaching Hospital, Toulon, France; Sponsored by Direction Centrale due Service de Sante des Armees
Hyperbaric Oxygen Therapy Effect in COVID-19 RCT
• Yitzhak Shamir Medical Center, Tel Aviv Israel; Sponsored by Assaf-Harofeh Medical Center
In an effort to support our hyperbaric chamber users, Sechrist Industries is available to review your facilities specific Infection Control Protocols with respect to your model Sechrist monoplace hyperbaric chamber. Our goal is to provide information that you may need regarding the technical components and aspects of your chamber.
ECMO (Extracorporeal Membrane Oxygenation) can be lifesaving in patients with severe forms of ARDS, or refractory cardio-circulatory compromise; patients whose heart or lungs have stopped working properly. The ECMO machine pumps blood from the patient’s body to an artificial lung (oxygenator) that adds oxygen to it and removes carbon dioxide. Thus, it replaces the function of the person’s own lungs. Air / Oxygen gas blenders provide fresh gas to the oxygenator. The desired fraction of oxygen is programmed and varies from 21% (room air) to 100%. Typically the blender is kept at 100% oxygen unless there are specific circumstances which dictate otherwise. Sechrist’s air / oxygen blender Model 3500CP-G is specifically designed for the use in ECMO and Heart-Lung bypass applications.
The ECMO machine then sends the blood back to the patient via a pump with the same force as the heart, replacing its function. The ECMO machine is controlled by a person called a perfusionist, or a nurse or respiratory therapist with advanced training called an ECMO specialist. The perfusionist or ECMO specialist will adjust the settings on the machine to give the patient the amount of heart and lung support they need.
On April 7, 2020, the FDA issued a guidance to provide a policy to help expand the availability of devices used in ECMO therapy to address the pandemic. (Enforcement Policy for Extracorporeal Membrane Oxygenation and Cardiopulmonary Bypass Devices During the Coronavirus Disease 2019 (COVID-19) Public Health Emergency). The new policy states that ECMO can be used for greater than six hours as a tool to treat COVID patients and lists all devices identified as being technologically capable of being used for ECMO therapy that can be used for COVID patients. ECMO can oxygenate a severely sick COVID pneumonia patient’s blood without the need to transfer the oxygen through fluid filled lungs. ECMO is recommended when conventional management fails; not the first option to replace ventilators, but an option that can buy time for critically ill patients
In the midst of the ever-changing landscape we are seeing in regards to the global pandemic, the team at Sechrist Industries is working tirelessly to ensure that we are here for you as you work to save the lives of those affected by COVID-19. Our entire team is here to support healthcare providers, and partners around the world. We are inspired every day by their acts of courage and compassion and by the commitment of our own employees in supporting them. We are honored to serve alongside the many who are working hard to deliver swift, efficient, and quality care in this time of need.
Our Purchasing team has reviewed if there is any potential impact to our supply chain as well as the production of our respiratory and hyperbaric products. The Sechrist team is continually in contact with all of our suppliers and at this time there is no issue with the continuity of items from our suppliers. Our team is continuing to monitor the situation and we are committed to continuing our supply to you, our valued customer.
The Sechrist Customer Service team is working two shifts and are available from 6:30am PST to midnight PST to ensure that we are available to all our customers worldwide. Whether by phone or email (CustomerService@SechristUSA.com), there is always someone who will be available to assist you.
The Hyperbaric Technical & Field Service teams are continuing to be accessible for assistance with technical support and troubleshooting as well as continuing to conduct installations, annual preventative maintenance and repairs. We know that many of you have taken steps to limit and adjust access to your facilities in an effort to combat the further spread of COVID-19. Our team is working with each customer to ensure that we meet your updated guidelines so that we can continue to keep your equipment optimally running to treat patients.
Our Sales and Marketing team is also there for you, whether it be remote, via phone or some other means of contact. We understand the challenges you are facing and we are committed to be there for you.
The Production team is working double shifts 6-days per week so that we can continue to meet all of our customer’s product needs. Every employee in our production department is dedicated to making sure that the product they produce for you is always of the highest quality and reliability. Each one knows the importance of their work so that you can be confident in the Sechrist products that you are using to save and improve lives.